| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/19/2011 | CN101153043B Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | CN101092397B Structure modified compound of sinomenine, and prepartion method |
| 01/19/2011 | CN101062330B Chinese medicine composition for improving sleeping and preparing method thereof |
| 01/19/2011 | CN101014578B Triazole derivative or salt thereof |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872127 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872098 derivatives of peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY pharmaceutical compositions; capable of stimulating in vitro the proliferation and the secretion of IL-2 by the CD4+ T cells purified from the ganglia |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872041 administering to the patient a compound selected from rotigotine, a physiologically acceptable salt of rotigotine, and a rotigotine prodrug, wherein the compound is administered to provide a rotigotine dosage of 0.05 mg to approximately 50 mg per day |
| 01/18/2011 | US7872035 Angiotensin II antagonists |
| 01/18/2011 | US7872030 Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 01/18/2011 | US7872023 Kappa opioid receptor ligands |
| 01/18/2011 | US7872017 such as 5-{5-[(endo)-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yloxy]-pyridin-2-yl}-1H-indole, having nicotinic receptors modualtory activity, used for the treatment of attention deficit disorder, senile dementia, Down's syndrome, amyotrophic lateral sclerosis, Huntington's, Pick's and Alzheimer's disease |
| 01/18/2011 | US7871998 Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity |
| 01/18/2011 | US7871992 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP) |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | CA2564201C Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2475630C N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/18/2011 | CA2385444C Humanin, a polypeptide suppressing neuronal death |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/18/2011 | CA2311125C Apoptosis inhibitor |
| 01/18/2011 | CA2310534C Methods and compositions for treating primary and secondary tumors of the central nervous system (cns) |
| 01/14/2011 | CA2709589A1 Civamide patch for localized post-incisional neuropathic pain |
| 01/13/2011 | WO2011006157A2 Rxr agonist compounds and methods |
| 01/13/2011 | WO2011006144A1 Methods of treating and preventing neurological disorders using docosahexaenoic acid |
| 01/13/2011 | WO2011006097A2 Methods For Treating Toxicity |
| 01/13/2011 | WO2011006066A1 Cb receptor agonists |
| 01/13/2011 | WO2011005969A2 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 01/13/2011 | WO2011005907A1 Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis |
| 01/13/2011 | WO2011005577A1 Zinc supplementation to increase responsiveness to metalloprotease therapy |
| 01/13/2011 | WO2011005520A1 Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators |
| 01/13/2011 | WO2011005052A2 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same |
| 01/13/2011 | WO2011004734A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
| 01/13/2011 | WO2011004196A1 Cyclic triazo sodium channel blockers |
| 01/13/2011 | WO2011004166A1 Combined preparation for use as a medicament |
| 01/13/2011 | WO2011003938A1 Salts of rasagiline and pharmaceutical preparations thereof |
| 01/13/2011 | WO2011003626A1 INDUCTION OF α-HELIX CONFORMATIONS IN PROTEINS AND PEPTIDES |
| 01/13/2011 | WO2011003418A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | WO2011003365A1 Histone deacetylase inhibitors with branched structure synthesized through click chemistry |
| 01/13/2011 | WO2011003226A1 Pharmaceutical composition for treating depression and preparative method and use thereof |
| 01/13/2011 | WO2010130771A3 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes |
| 01/13/2011 | WO2010107866A3 Catecholamine derivatives for obesity and neurological disorders |
| 01/13/2011 | WO2010105191A3 Antimicrobial compositions and methods of use therefore |
| 01/13/2011 | WO2010096384A3 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands |
| 01/13/2011 | US20110010785 Products and their use for the diagnosis, prevention and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009492 ß-PHENYLETHYLIDENEHYDRAZINE DERIVATIVES |
| 01/13/2011 | US20110009485 Synthesis of scabronines and analogues thereof |
| 01/13/2011 | US20110009479 Stimulating Neuronal Growth Using Brevetoxins |
| 01/13/2011 | US20110009475 Methods for treating stress induced emotional disorders |
| 01/13/2011 | US20110009465 3-phenoxymethylpyrrolidine compounds |
| 01/13/2011 | US20110009461 2-aza-bicyclo[3.3.0]octane derivatives |
| 01/13/2011 | US20110009460 Compositions and methods for treating amyotrophic lateral sclerosis |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009449 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009445 Neuroprotectants |
| 01/13/2011 | US20110009444 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009441 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 01/13/2011 | US20110009440 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 01/13/2011 | US20110009437 Carboxamide-heteroaryl derivatives for the treatment of diabetes |
| 01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
| 01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
| 01/13/2011 | US20110009423 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/13/2011 | US20110009422 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
| 01/13/2011 | US20110009421 Compound having 6-membered aromatic ring |
| 01/13/2011 | US20110009420 Histamine H3 Receptor Ligands |
| 01/13/2011 | US20110009419 Enantiomers of 2'-Fluoralkyl-6-nitroquipazine as Serotonin Transporter Positron Emission Tomography Imaging Agents and Antidepressant Therapeutics |
| 01/13/2011 | US20110009417 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/13/2011 | US20110009415 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses |
| 01/13/2011 | US20110009413 Cyclic triazo and diazo sodium channel blockers |
| 01/13/2011 | US20110009410 Apoptosis signal-regulating kinase inhibitors |
| 01/13/2011 | US20110009401 2-aza-bicyclo[2.2.1]heptane derivatives |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009395 Bace inhibitors |
| 01/13/2011 | US20110009392 Gamma secretase modulators |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009382 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles |
| 01/13/2011 | US20110009380 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 01/13/2011 | US20110009378 Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009365 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009364 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009360 Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis |
| 01/13/2011 | US20110009357 Lipid composition for improving brain function |
| 01/13/2011 | US20110009349 Methods of maintaining or increasing growth or cognitive development |
| 01/13/2011 | US20110009343 Modulators of amyloid aggregation |